Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
Biochemical Pharmacology|January 20, 1994
2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in cultureA H Cory, V Samano, M J Robins, et al.Oncology Research|January 1, 1996
Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazoneA H Cory, A Sato, D P Thompson, et al.Cancer Research|November 15, 1988
Liver microsomal inactivation of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone as an inhibitor of ribonucleotide reductaseM T Williams, L Simonet, A H Cory, et al.The Australian and New Zealand Journal of Psychiatry|May 7, 2002
Lithium toxicity: an iatrogenic problem in susceptible individualsP W Oakley, I M Whyte, G L CarterAdvances in Enzyme Regulation|January 1, 1997
Alterations in the properties of mouse leukemia L1210 cell lines selected by different methods for resistance to deoxyguanosineJ G Cory, T O Nelson, L Somerville, et al.The Journal of Biological Chemistry|January 5, 1993
Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activityA H Cory, I A Shibley, J M Chalovich, et al.Anticancer Research|April 13, 2001
Increased sensitivity to sodium salicylate-induced apoptosis in drug-resistant leukemia L1210 cellsJ G Hall, A H Cory, D H Hickerson, et al.Oncology Research|January 1, 1993
Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cellsA H Cory, L W Hertel, J S Kroin, et al.Oncology Research|January 1, 1992
5-hexyl-2'-deoxyuridine inhibition of nucleoside transport in L1210 cellsJ G Cory, D L Downes, C Y Ng, et al.Cancer Communications|July 1, 1991
Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in cultureA H Cory, T C Owen, J A Barltrop, et al.Pageof 11